|
XenoSystems maintains a diverse portfolio of intellectual property (IP), such
as copyrights, trademarks, trade secrets, trade dress, and technical expertise.
Like other major technology providers, XenoSystems applies to governments
around the world to obtain patents on our inventions as necessary. A patent
establishes ownership of an invention, enabling the patent owner to benefit
commercially from investments in innovation. A patent is granted if government
patent examiners conclude that an invention is a true innovation compared with
existing technology.
Parties interested in licensing XenoSystems IP are encouraged to contact our
Intellectual Property and Licensing Group at
intellectual property. To promote broader availability and use of our technologies, XenoSystems may
periodically publish new licensing programs on www.XenoSystems.com.
With respect to patents, XenoSystems will generally license our patents under
fair and reasonable terms so long as licensees respect XenoSystems'
intellectual property rights. These licensing terms are similar to how others
in the technology industry license their own patents, typically referred to as
"commercially reasonable" terms. Where XenoSystems determines to license
patents, we will generally do so nonexclusively. For products that practice
XenoSystems patents, the royalty rates will follow industry norms. XenoSystems
will consider all requests for licenses but reserves the right not to license
certain IP. For example, XenoSystems will generally not license patents,
including design patents, which differentiate the appearance of XenoSystems
products and services.
- Application to academics.
For bona-fide academic institutions, XenoSystems will make available
appropriate royalty-free covenants under its patents. These royalty-free
covenants are intended to encourage noncommercial research and educational
activities.
-
Application to existing standards commitments. XenoSystems will continue
to comply with all applicable policies when participating in industry standards
processes, including the contribution of technology to standards bodies under
"reasonable and nondiscriminatory" (RAND) terms, either on a for-fee, or
royalty-free basis, as defined by each standards group.
This policy statement highlights XenoSystems' current licensing practices and is
subject to change at any time, as well as to variation to conform to applicable
laws and regulations.
Contact Us
For XenoSystems licensing information, please contact us by e-mail at
intellectual property.
For More Information
Learn more about intellectual property.
|